Adenocarcinoma Doctors Abroad — Page 2

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University, where he led the department in treatring complex solid tumours.

• Specialises in medical oncology for adenocarcinoma and other gastrointestinal cancers
• Former Education Officer at Prof Dr Cemil Taşçıoğlu City Hospital, training the next generation of oncologists
• Expertise in internal medicine, providing a whole-body approach to cancer care
• Published researcher focused on improving clinical outcomes in medical oncology

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Serkan Keskin is a top-ranked oncologist who achieved first place in Turkey's national medical oncology proficiency exam.

• Performs 1,100+ oncology procedures annually at Memorial Şişli Hospital
• Uses targeted therapy and immunotherapy to treat complex adenocarcinoma cases
• Active member of the American Society of Clinical Oncology (ASCO)
• Published 42 research articles on cancer treatment in international journals
• Award-winning specialist recognised for clinical excellence at the National Cancer Congress

Professor Yesim Yildirim is a leading medical oncologist at Anadolu Medical Center, specialising in immunotherapy and targeted treatments for gastrointestinal and lung adenocarcinomas.

• Followed specialist training in immunooncology at the Mount Vernon Cancer Center in London
• Co-authored the international handbook on precision medicine and advanced cancer care
• Holds a formal attestation from the European Society of Medical Oncology (ESMO)
• Professor at Halic University with over 80 peer-reviewed medical publications
• Specialises in targeted therapies that attack cancer cells while sparing healthy tissue

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr Rahib Hasanov provides personalised immunotherapy and targeted drug treatments at Hisar Hospital, following advanced training at the Houston Methodist Hospital in Texas.

• Specialises in gastrointestinal adenocarcinoma including stomach, pancreas and oesophageal cases
• Uses smart drugs and immunotherapies to target cancer cells while sparing healthy tissue
• Trained at Istanbul University Cerrahpasa, a leading Turkish medical faculty with an English programme
• Fellowship-trained in medical oncology with a focus on urogenital and breast cancers
• Manages complex cases for international patients from Europe and the United States

Professor Sezer Saglam is a renowned gastrointestinal oncology specialist at Istanbul Florence Nightingale Hospital with a record of 1,100 successful treatments.

• Nominated for the International Best Researcher Award for work in liver-transplant oncology
• Specialises in gastrointestinal adenocarcinoma and neuroendocrine tumours
• Holds a fellowship from the Istanbul University Oncology Institute
• Member of the European Neuroendocrine Tumour Society (ENET)
• Active member of the American Society of Clinical Oncology (ASCO)

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr Tahsin Ozadli has managed over 1,100 oncology treatments, specialising in internal medicine and medical oncology at Valued Med Hub Hospitals.

• Specialises in gastric and oesophageal adenocarcinoma cases
• Trained at the Ankara Oncology Training and Research Hospital
• Focuses on targeted medical therapies for lung and breast cancers
• Practised oncology at the Erzurum Regional Training and Research Hospital
• Active clinical researcher with numerous peer-reviewed oncology publications

Professor Saban Sec is a leading specialist representative for the Turkish Medical Oncology Association, focusing on high-risk adenocarcinoma cases at Valued Med Hub Hospitals.

• Specialises in gastrointestinal cancers, including colon, rectum, liver, and stomach adenocarcinomas
• Researched BRCA mutation profiles to improve treatment for high-risk breast cancer patients
• Uses perioperative FLOT protocols – intensive chemotherapy to shrink tumours before and after surgery
• Expert in managing HER2-positive metastatic gastric cancer and rare salvary gland tumours
• Evaluates metabolic tumour volume to predict how patients will respond to chemotherapy